CFDE Data Portal | Search RPL21P45

	Label	Description
	RPL21P45 associations Collection (Entity type)	Associations for RPL21P45_associations
	RPL21P45 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	RPL21P45 Gene (Entity type)	ENSG00000239532 - ribosomal protein L21 pseudogene 45
	GSE263012 LBR knockout K-562 Lamin Type A 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE147816 GSE147817 LSD1 inhibition McCoy 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Prostate 20-29 vs 70-79 Up Gene Set (Entity type)	A Gene Set from GTEx
	GSE263012 LBR knockout K-562 Lamin Type A 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE188631 DREAM knockout HeLa 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS

RPL21P45 associations

Associations for RPL21P45_associations

RPL21P45 associations.tsv

A file from IDG as part of the Harmonizome project

RPL21P45

ENSG00000239532 - ribosomal protein L21 pseudogene 45

GSE263012 LBR knockout K-562 Lamin Type A 1 v 0 human dn

A Gene Set from LINCS

GSE147816 GSE147817 LSD1 inhibition McCoy 3 v 2 human up

A Gene Set from LINCS

GTEx Prostate 20-29 vs 70-79 Up

A Gene Set from GTEx

GSE263012 LBR knockout K-562 Lamin Type A 1 v 2 human dn

A Gene Set from LINCS

GSE188631 DREAM knockout HeLa 0 v 2 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 4 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.